JGP Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,095 shares of the medical equipment provider’s stock after acquiring an additional 44 shares during the quarter. JGP Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,094,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth $33,000. Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical in the second quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at about $38,000. Finally, DT Investment Partners LLC boosted its holdings in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Up 0.7 %
Shares of ISRG stock opened at $584.08 on Friday. The firm has a market cap of $208.04 billion, a PE ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $585.50. The company’s fifty day simple moving average is $538.34 and its 200-day simple moving average is $497.08.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ISRG. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Raymond James boosted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $554.17.
Read Our Latest Stock Report on ISRG
Insider Activity at Intuitive Surgical
In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is owned by insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Invest in the Best Canadian StocksĀ
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Investing in Construction Stocks
- Micron Technology: Riding the AI Wave to Long-Term Growth
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.